Despite recent revenue growth, the company's high P/S ratio ...
Despite recent revenue growth, the company's high P/S ratio and below-average growth rates suggest investors are banking on a business turnaround. Continuation of medium-term revenue trends could hurt the share price.
Some Zhejiang Yatai Pharmaceutical Co., Ltd. (SZSE:002370) Shareholders Look For Exit As Shares Take 26% Pounding
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment